Assoc/Prof. Salvatore Pepe is a clinical scientist who leads the Molecular & Cellular Cardiology Laboratory in the Heart Research Group (Clinical Sciences Theme) at the Murdoch Children's Research Institute (MCRI) and is a clinical research manager in the Department of Cardiology, Royal Children's Hospital.
Before working at Melbourne Children's Campus, he was Head of the Cardiothoracic Surgical Research Laboratory, (Department of Cardiothoracic Surgery), at the Alfred Hospital, and Adjunct Senior Lecturer, Department of Surgery -Alfred, Central Clinical School, Monash University, involved in clinical trial and laboratory research focused on cellular and mitochondrial processes in heart failure, transplantation, and cardiopulmonary bypass surgery. Earlier posts include a Research Fellowship at the Baker Heart Research Institute, Melbourne, and a National Institutes of Health Fogarty Postdoctoral Fellowship at the Gerontology Research Center, (LCS, IRP, NIA, NIH) Johns Hopkins Hospital, Bayview Campus, Baltimore, USA.
Working with cardiac surgery, cardiology and intensive care clinicians, Dr Pepe's work is focused on complications arising from congenital and acquired heart and lung disorders, premature birth and surgical interventions. His research program spans from in vitro and in vivo laboratory studies to clinical trials, translating new understanding of disease mechanisms and novel therapy to clinical use. Currently he is Chief Investigator A of an NHMRC funded clinical trial, testing the safety and efficacy of cord blood stem cell therapy in children at risk of heart failure.
A/Prof Pepe is Deputy Editor-in-Chief of Australia's premiere cardiology research journal, Heart Lung & Circulation (Elsevier, Sydney), and is also an Associate Editor for Heliyon-Clinical Research (Cell Press-Elsevier, London UK), and Frontiers in Cardiovascular Medicine -Cardiovascular Biologics & Regenerative Medicine (Lausanne, Switzerland). A/Prof Pepe has regularly served NHMRC, NHF and ARC as a grant funding panel member and external expert grant reviewer and is an invited peer reviewer for numerous medical and scientific journals. He is Past-President of the International Society for Heart Research and recipient of the 2016 ISHR Distinguished Leader Award. He is an international Fellow of the American Heart Association and a Fellow of the Cardiac Society of Australia and New Zealand.
Assoc/Prof. Salvatore Pepe is a clinical scientist who leads the Molecular & Cellular Cardiology Laboratory in the Heart Research Group (Clinical Sciences Theme) at the Murdoch Children's Research Institute (MCRI) and is a clinical research manager in...
Assoc/Prof. Salvatore Pepe is a clinical scientist who leads the Molecular & Cellular Cardiology Laboratory in the Heart Research Group (Clinical Sciences Theme) at the Murdoch Children's Research Institute (MCRI) and is a clinical research manager in the Department of Cardiology, Royal Children's Hospital.
Before working at Melbourne Children's Campus, he was Head of the Cardiothoracic Surgical Research Laboratory, (Department of Cardiothoracic Surgery), at the Alfred Hospital, and Adjunct Senior Lecturer, Department of Surgery -Alfred, Central Clinical School, Monash University, involved in clinical trial and laboratory research focused on cellular and mitochondrial processes in heart failure, transplantation, and cardiopulmonary bypass surgery. Earlier posts include a Research Fellowship at the Baker Heart Research Institute, Melbourne, and a National Institutes of Health Fogarty Postdoctoral Fellowship at the Gerontology Research Center, (LCS, IRP, NIA, NIH) Johns Hopkins Hospital, Bayview Campus, Baltimore, USA.
Working with cardiac surgery, cardiology and intensive care clinicians, Dr Pepe's work is focused on complications arising from congenital and acquired heart and lung disorders, premature birth and surgical interventions. His research program spans from in vitro and in vivo laboratory studies to clinical trials, translating new understanding of disease mechanisms and novel therapy to clinical use. Currently he is Chief Investigator A of an NHMRC funded clinical trial, testing the safety and efficacy of cord blood stem cell therapy in children at risk of heart failure.
A/Prof Pepe is Deputy Editor-in-Chief of Australia's premiere cardiology research journal, Heart Lung & Circulation (Elsevier, Sydney), and is also an Associate Editor for Heliyon-Clinical Research (Cell Press-Elsevier, London UK), and Frontiers in Cardiovascular Medicine -Cardiovascular Biologics & Regenerative Medicine (Lausanne, Switzerland). A/Prof Pepe has regularly served NHMRC, NHF and ARC as a grant funding panel member and external expert grant reviewer and is an invited peer reviewer for numerous medical and scientific journals. He is Past-President of the International Society for Heart Research and recipient of the 2016 ISHR Distinguished Leader Award. He is an international Fellow of the American Heart Association and a Fellow of the Cardiac Society of Australia and New Zealand.
Top Publications
Pepe, S.
Erratum to “Effect of dietary polyunsaturated fatty acids on age-related changes in cardiac mitochondrial membranes” [Experimental Gerontology 40/5(2005) 369–376].
Experimental Gerontology
40(8-9)
:
750
2005
view publication
Pepe, S.
Effect of dietary polyunsaturated fatty acids on age-related changes in cardiac mitochondrial membranes.
Experimental Gerontology
40(5)
:
369 -376
2005
view publication
Pepe, S, Lakatta, EG.
Aging hearts and vessels: Masters of adaptation and survival.
Cardiovascular Research
66(2)
:
190 -193
2005
view publication
Swarbrick, JD, Buyya, S, Gunawardana, D, Fletcher, JI, Branson, K, Smith, B, Pepe, S, McLennan, AG, Gayler, KR, Gooley, PR.
Letter to the Editor: 1H, 13C, and 15N resonance assignments of the 17 kDa Ap4A hydrolase from Homo sapiens in the presence and absence of ATP.
Journal of Biomolecular NMR
31(2)
:
181 -182
2005
view publication
Rosenfeldt, F, Marasco, S, Lyon, W, Wowk, M, Sheeran, F, Bailey, M, Esmore, D, Davis, B, Pick, A, Rabinov, M, et al.
Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue.
Journal of Thoracic and Cardiovascular Surgery
129(1)
:
25 -32
2005
view publication